Zentraxa’s proprietary technological platform, Zentide, combined with our extensive technical know-how allows us to push the boundaries of what can be achieved with synthetic biopolymers. We specialise in the design, production and testing of complex novel peptides and, as a result of our Zentide platform, can circumvent the previously existing bio-design limits of conventional peptide synthesis with one universal process.
Company Details
- Employees
- 13
- Founded
- 2017
- Address
- Unit Dx, St Phillips Central, Albert Road,united Kingdom
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- zentraxa.com
- Keywords
- Bristol.
- HQ
- Bristol, England
Zentraxa Questions
Zentraxa's website is zentraxa.com
Zentraxa's LinkedIn profile is https://uk.linkedin.com/company/zentraxa
Zentraxa has
13 employees.
View email and phone details for 13
employees at Zentraxa.
Zentraxa's industry is
Biotechnology Research
Zentraxa's top competitors are
Cytoseek,
Polynt Group,
Exmoor Pharma,
Scarlet Therapeutics Ltd,
Genomekey,
Science Creates,
Fluoretiq Limited,
Folium Science,
Extracellular,
Twig Bio.
Zentraxa's categories are Biotechnology Research
Zentraxa's founding year is 2017
